{
    "clinical_study": {
        "@rank": "121020", 
        "arm_group": [
            {
                "arm_group_label": "Walking", 
                "arm_group_type": "Active Comparator", 
                "description": "WALK. The participants were instructed to walk daily, at first week 12minutes/day, week II 16mins/day, week III 20mins/day, week IV 24 mins/day, week V 28mins/day, week VI 32mins/day at a pace that would moderately increase heart rate and result in sweating"
            }, 
            {
                "arm_group_label": "Hula-hooping", 
                "arm_group_type": "Active Comparator", 
                "description": "HULA. The participants were instructed to hula hoop daily, at first week 6minutes/day, week II 8mins/day, week III 10mins/day, week IV 12 mins/day, week V 14mins/day, week VI 16mins/day"
            }
        ], 
        "brief_summary": {
            "textblock": "o determine effects of  hula-hooping on android obesity, metabolic parameters and adipose\n      tissue (AT) gene expression."
        }, 
        "brief_title": "Effect of Hula Hooping as Compared to Walking on Adipose Tissue Distribution, Metabolic Parameters and Adipose Tissue Gene Expression", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": "Android Obesity, Metabolic Parameters and Adipose Tissue (AT) Gene Expression", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 70 years\n\n          -  central adiposity as measured by the waist circumference (>80 cm in females and >94\n             cm in males) (9)\n\n          -  ability to hula-hoop for a minimum of 2 minutes and to have the necessary space\n             available for this activity either at home or at work\n\n          -  ability to communicate meaningfully with the investigator and legal competence to\n             provide written informed consent\n\n        Exclusion Criteria:\n\n          -  clinical or biochemical evidence of disease other than obesity as judged by history,\n             physical examination and standard laboratory tests\n\n          -  excessive use of alcohol, i.e., over 20 g/day\n\n          -  use of medications known to affect glucose or lipid metabolism and\n\n          -  pregnancy or lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913171", 
            "org_study_id": "HULA 233401", 
            "secondary_id": "HULA233401"
        }, 
        "intervention": {
            "arm_group_label": [
                "Walking", 
                "Hula-hooping"
            ], 
            "intervention_name": "Exercise", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Helsinki", 
                    "country": "Finland", 
                    "zip": "FI-00290"
                }, 
                "name": "Department of Medicine, University of Helsinki"
            }
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Hula Hooping as Compared to Walking on Adipose Tissue Distribution, Metabolic Parameters and Adipose Tissue Gene Expression", 
        "other_outcome": {
            "description": "To determine the effects of HULA compared to WALK on adipose tissue inflammation, a needle aspiration biopsy of abdominal s.c. adipose tissue was taken under local anesthesia with lidocaine before and after each exercise intervention. The adipose tissue sample was immediately frozen in liquid nitrogen and then stored at -80\u00b0C until analysis. Total RNA from s.c. AT was isolated.Relative quantification for the genes of interest (see list below) was carried out using normalization to the 36B4 and \u03b2-actin mRNA values.\nABCA1 Adiponectin ANGPTL8 CHOP CD4 CD8 CD68 ETFDH FOXP3 GLUT4 MCP-1 MRC-1 PGC-1\u03b1 VEGF-A \u03b2-actin", 
            "measure": "adipose tissue inflammation", 
            "safety_issue": "Yes", 
            "time_frame": "6weeks"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Finland: University of Helsinki / Department of internal medisine / Devision of diabetes", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary objective was to evaluate the change in the % fat in the android region as measured by DEXA during 6 weeks of HULA as compared to WALK", 
            "measure": "Android obesity", 
            "safety_issue": "Yes", 
            "time_frame": "6weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913171"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Helsinki University", 
            "investigator_full_name": "Sanja Sadevirta", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The secondary objectives included the comparison of differences in waist circumference (cm), relative and absolute trunk and limb muscle mass as measured by DEXA (% and kg), fasting plasma glucose (mmol/l), fasting serum insulin (mU/l), liver enzymes (U/l), fasting plasma LDL and HDL cholesterol and triglycerides (mmol/l). Gene expression was analyzed in adipose tissue biopsies collected before and after each exercise intervention.", 
            "measure": "metabolic parameters", 
            "safety_issue": "Yes", 
            "time_frame": "6weeks"
        }, 
        "source": "Helsinki University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Helsinki University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}